The Value of CE/CME to Improve Outcomes in Community Oncology Practice

Activity Details
  • Credit Amounts:
    • CME: 1.00
    • CPE: 1.00
    • CNE: 1.00
    • Other: 1.00
  • Cost: Free
  • Release: Oct 2, 2018
  • Expires: Oct 2, 2019
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Needs Statement

The field of oncology is rapidly evolving, with targeted treatment approaches and immunotherapies broadening horizons for patients and practitioners alike. However, this ongoing evolution makes it difficult for oncologists to stay current with evidence-based treatment guidelines. The challenge is particularly pronounced in the community setting, where cancer incidence rates may be lower and death rates are higher than those seen in academic medical centers. The goal of this activity is to examine adaptive educational strategies for overcoming the oncology outcomes disparity between community and academic practice settings. Continuing medical education (CME) has been shown to impact not only clinician competence and performance, but actual patient health outcomes. Participants in this activity will be introduced to creative CME implementation strategies and innovative design formats, each with the singular goal of tailoring educational programs to the specific needs of clinicians across the practice spectrum.

Target Audience

Physicians, pharmacists, nurses, educators, and other healthcare education stakeholders who are interested in improving patient care through the provision of continuing medical education activities.


At the conclusion of this knowledge-based activity, the participant will be able to:

  • Examine disparities in oncology practice patterns and patient outcomes based on geographic location and clinician practice setting.
  • Discuss novel and adaptive educational strategies for bridging practice gaps between community cancer practices/clinics and academic medical centers.
  • Analyze and consider examples of effective educational design in community oncology education.


In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medicine (ACCME)

CEC designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy (ACPE)

This knowledge-based activity is approved for 1.0 contact hour (.10 CEUs) of continuing pharmacy education credit (JA0007101-0000-18-014-L01-P)

Nursing (ANCC)

This activity is designated for 1.0 contact hour.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Faculty Disclosure

In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.

Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial interest is defined as an entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients. Relevant relationships include receiving from a commercial interest research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.

Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Joan B. Fowler, PharmD, BCPP–has no relevant financial relationships to disclose in relation to the content of this activity.

Bryan C. Taylor, PharmD–has no relevant financial relationships to disclose in relation to the content of this activity.
Jeffrey S. Weber, MD, PhD–has disclosed that he is a consultant for Amgen, AstraZeneca, Bristol-MyersSquibb, Celldex, CytomX, EMD Serono, Genentech, GlaxoSmithKline, Incyte, Merck, Sellas, and Windmill. His institution receives grant/research support from AstraZeneca, Bristol-Myers Squibb, EMD Serono, GlaxoSmithKline, Incyte, and, Merck.

Peer Reviewer:
Adrienne W. Matson, PharmD, BCPS–has no relevant financial relationships to disclose in relation to the content of this activity.


This activity is sponsored by Creative Educational Concepts and is supported by an independent educational grant from AstraZeneca.